|
시장보고서
상품코드
2052383
통증 관리 기기 시장 : 종류별, 용도별, 최종사용자별, 지역별Pain Management Devices Market, by Type, By Application, by End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
통증 관리 기기 시장은 2026년에 51억 8,100만 달러로 추정되며, 2033년까지 81억 5,770만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.7%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 51억 8,100만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 6.70% | 2033년 시장 규모 예측: | 81억 5,770만 달러 |
통증 관리 기기에는 암성 통증, 통각수용성 통증, 근골격계 통증 등의 치료용 기기가 포함됩니다. 시장에는 절제장치, 경피적 전기신경자극기(TENS), 진통제 주입펌프, 척수자극기 등 다양한 통증 치료 장비가 존재합니다. 이 기기들은 통증의 원인에 직접 작용하여 통증 신호를 차단하거나 환부에 직접 약물을 투여하는 등 다양한 방법으로 통증을 완화합니다. 개인의 필요와 질환에 가장 적합한 통증 관리 기기를 결정하기 위해서는 의료 전문가와 상담하는 것이 중요합니다. 고가의 침습적인 이식형 장치는 보다 덜 침습적이고 비용이 적게 드는 치료법으로 통증과 고통을 완화하지 못한 경우에만 효과적인 치료법으로 사용해야 합니다. 적절한 근거에 따라 적절한 환자에게 사용되었을 때, 척수자극요법은 신경인성 통증 신호에 대해서는 신경조절 작용을 하지만, 통각수용성 통증 신호에 대해서는 신경조절 작용을 하지 않습니다. 그 결과, 유효성이 검증된 환자에서 장기적인 통증 완화율이 약 60-80%에 달하는 것으로 나타났습니다.
시장 역학
신경조절장치는 주로 통증, 간질, 진전, 뇌졸중 등 신경질환의 증상을 치료하고 완화하는 데 사용됩니다. 또한, 신경조절 장치는 노화 및 신경증과 관련된 다양한 질환의 치료에도 사용되고 있습니다. 신경질환의 유병률 증가, 비오피오이드 치료의 대중화, 신경자극기기가 다양한 이점을 제공한다는 점 등이 시장 확대에 기여하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 기술 발전, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서에서는 다음과 같은 매개변수(회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 세계 통증 관리 장치 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계 통증 관리 장치 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 통증 관리 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 통증 관리 기기 시장 : 유형별, 2021-2033년
제5장 세계의 통증 관리 기기 시장 : 용도별, 2021-2033년
제6장 세계의 통증 관리 기기 시장 : 최종사용자별, 2021-2033년
제7장 세계의 통증 관리 기기 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSMPain Management Devices Market is estimated to be valued at USD 5,181.0 Mn in 2026 and is expected to reach USD 8,157.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5,181 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.70% | 2033 Value Projection: | USD 8,157.7 Mn |
Pain management devices include those for cancer pain, nociceptive pain, musculoskeletal pain, and others. There are many different kinds of pain treatment equipment on the market, including ablation devices, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and spinal cord stimulators. These devices work by targeting the source of pain and providing relief through various methods, such as blocking pain signals or releasing medication directly to the affected area. It is important to consult with a healthcare professional to determine the best pain management device for individual needs and conditions. Costly and invasive implantable devices should only be utilized as effective treatments when less aggressive and expensive ones have failed to relieve pain and suffering. When used for the correct reasons by the right people, spinal cord stimulation neuromodulates neuropathic pain signals but not nociceptive pain signals. This results in roughly 60-80% long-term pain alleviation in patients who were tested for efficacy.
Market Dynamics
Devices for neuromodulation are primarily used to treat and reduce the symptoms of neurological illnesses', such as pain, epilepsy, tremor, stroke, etc. Additionally, neuromodulation devices are usedto treat a variety of illnesses linked to aging and neurotic conditions. The prevalence of neurological illnesses is increasing, non-opioid treatments are becoming more popular, and neurostimulation devices provide a variety of advantages, all of which contribute to the market's expansion.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, technology advancement, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global pain management devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Stryker Corporation, Pfizer Inc. (Hospira Inc.), Medtronic Plc, Boston Scientific Corporation, Baxter International Inc., Braun Melsungen AG, Abbott Laboratories, Colfax Corporation (Djo Global LLC), Kimberly-Clark Corporation (Baylis Medical), Johnson & Johnson (Codman and Shurtleff, Inc.), Neuspera Medical, ZetrOZ Systems, Therabody, BioElectronics Corporation, Nevro Corp, Stevanato Group S.p.A., Bexson Biomedical, Inc., SPR Therapeutics, Lumaflex, Saluda Medical Pty Limited, DyAnsys Inc., Pacira BioSciences, Inc., InterSystems, Nalu Medical, Inc., and StimaWELL North America Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global pain management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management devices market.
Market Segmentation
- Global Pain Management Devices Market, By Type (Revenue, USD Mn, 2021 - 2033)
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps
- Ablation Devices
- Global Pain Management Devices Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Neuropathic Pain
- Cancer Pain
- Facial & Migraine Pain
- Musculoskeletal Pain
- Others
- Global Pain Management Devices Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Clinics
- Others
- Global Pain Management Devices Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Stryker Corporation
- Pfizer Inc. (Hospira Inc.)
- Medtronic Plc
- Boston Scientific Corporation
- Baxter International Inc.
- Braun Melsungen AG
- Abbott Laboratories
- Colfax Corporation (Djo Global LLC)
- Kimberly-Clark Corporation (Baylis Medical)
- Johnson & Johnson (Codman and Shurtleff, Inc.)
- Neuspera Medical
- ZetrOZ Systems
- Therabody Inc.
- BioElectronics Corporation
- Nevro Corp.
- Stevanato Group S.p.A.
- Bexson Biomedical, Inc.
- SPR Therapeutics
- Lumaflex
- Saluda Medical Pty Limited
- DyAnsys Inc.
- Pacira BioSciences, Inc.
- InterSystems
- Nalu Medical, Inc.
- StimaWELL North America Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Technology Advancement
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Pain Management Devices Market, By Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Neuromodulation & Neurostimulation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Analgesic Infusion Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Ablation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Pain Management Devices Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Neuropathic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cancer Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Facial & Migraine Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Musculoskeletal Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Pain Management Devices Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Pain Management Devices Market, By Region, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc. (Hospira Inc.)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B.Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Colfax Corporation (Djo Global LLC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kimberly-Clark Corporation (Baylis Medical)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson (Codman and Shurtleff, Inc.)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Neuspera Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ZetrOZ Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Therabody
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioElectronics Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nevro Corp.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Stevanato Group S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bexson Biomedical, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SPR Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lumaflex
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Saluda Medical Pty Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- DyAnsys Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pacira BioSciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- InterSystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nalu Medical, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- StimaWELL North America Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
